For: | Miuli A, Sepede G, Stigliano G, Mosca A, Di Carlo F, d’Andrea G, Lalli A, Spano MC, Pettorruso M, Martinotti G, di Giannantonio M. Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis. World J Psychiatr 2021; 11(8): 477-490 [PMID: 34513609 DOI: 10.5498/wjp.v11.i8.477] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v11/i8/477.htm |
Number | Citing Articles |
1 |
Sujita Kumar Kar, Amit Singh, Abhay Narayan Dwivedi. Mania triggered by intermittent theta burst stimulation—A case study. Indian Journal of Psychiatry 2023; 65(9): 980 doi: 10.4103/indianjpsychiatry.indianjpsychiatry_438_23
|
2 |
Larissa Gama-Chonlon, James M. Scanlan, Rebecca M. Allen. Could bipolar depressed patients respond better to rTMS than unipolar depressed patients? A naturalistic, observational study. Psychiatry Research 2022; 312: 114545 doi: 10.1016/j.psychres.2022.114545
|
3 |
Mauro Pettorruso, Giacomo d’Andrea, Francesco Di Carlo, Luisa De Risio, Francesca Zoratto, Andrea Miuli, Beatrice Benatti, Matteo Vismara, Enrico Pompili, Giuseppe Nicolò, Cinzia Niolu, Alberto Siracusano, Stefano S. Sensi, Bernardo Dell’Osso, Giorgio Di Lorenzo, Giovanni Martinotti, Giulia Giovannetti, Giulia Stefanelli, Clara Cavallotto, Ottavia Susini, Rosalba Carullo, Gianluca Mancusi, Ornella Di Marco, Mario Santorelli, Fabrizio Martino, Alessia Nicita, Laura Bernabei, Federica Tarallo, Alessandra Corrado, Luca Carlone. Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine. Brain Stimulation 2023; 16(4): 1041 doi: 10.1016/j.brs.2023.06.003
|
4 |
Giacomo d’Andrea, Gianluca Mancusi, Maria Chiara Santovito, Carlotta Marrangone, Fabrizio Martino, Mario Santorelli, Andrea Miuli, Francesco Di Carlo, Maria Salvina Signorelli, Massimo Clerici, Mauro Pettorruso, Giovanni Martinotti. Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions. Journal of Personalized Medicine 2023; 13(4): 697 doi: 10.3390/jpm13040697
|
5 |
Annelies Dellink, Kaat Hebbrecht, Dieter Zeeuws, Chris Baeken, Gerard De Fré, Chris Bervoets, Sara De Witte, Bernard Sabbe, Manuel Morrens, Violette Coppens. Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites. Journal of Affective Disorders 2024; 361: 693 doi: 10.1016/j.jad.2024.06.078
|
6 |
Giovanni Martinotti, Bernardo Dell'Osso, Giorgio Di Lorenzo, Giuseppe Maina, Alessandro Bertolino, Massimo Clerici, Stefano Barlati, Gianluca Rosso, Marco Di Nicola, Matteo Marcatili, Giacomo d'Andrea, Clara Cavallotto, Stefania Chiappini, Sergio De Filippis, Giuseppe Nicolò, Pasquale De Fazio, Ileana Andriola, Raffaella Zanardi, Domenica Nucifora, Stefania Di Mauro, Roberta Bassetti, Mauro Pettorruso, Roger S. McIntyre, Stefano L. Sensi, Massimo di Giannantonio, Antonio Vita. Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression. Bipolar Disorders 2023; 25(3): 233 doi: 10.1111/bdi.13296
|
7 |
Mary Lou Chatterton, Yong Yi Lee, Long Khanh-Dao Le, Melanie Nichols, Rob Carter, Michael Berk, Cathrine Mihalopoulos. Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression. Journal of Affective Disorders 2024; 356: 639 doi: 10.1016/j.jad.2024.04.075
|
8 |
Giacomo d'Andrea, Luisa De Risio, Giorgio Di Lorenzo, Francesca Zoratto, Enrico Pompili, Giuseppe Nicolò, Giovanni Camardese, Giovanni Martinotti, Mauro Pettorruso. An open-label pilot trial of a five-day, accelerated rTMS protocol in bipolar II depression. Journal of Affective Disorders 2025; 369: 146 doi: 10.1016/j.jad.2024.09.159
|
9 |
Steven Marwaha, Edward Palmer, Trisha Suppes, Emily Cons, Allan H Young, Rachel Upthegrove. Novel and emerging treatments for major depression. The Lancet 2023; 401(10371): 141 doi: 10.1016/S0140-6736(22)02080-3
|
10 |
Maria Buthut, David Haslacher, Surjo R. Soekadar. Behandlung depressiver Störungen mittels nicht invasiver Neuromodulation. Nervenheilkunde 2023; 42(07/08): 438 doi: 10.1055/a-2049-9967
|
11 |
Sean J. O’Sullivan, Derrick M. Buchanan, Jean-Marie V. Batail, Nolan R. Williams. Should rTMS be considered a first-line treatment for major depressive episodes in adults?. Clinical Neurophysiology 2024; 165: 76 doi: 10.1016/j.clinph.2024.06.004
|